Skip to main content

Table 1 Microbiological characteristics of the 35 representative CIP-R E. coli; phylogroups, MLST STs (clonal complexes; Cplx), presence/absence of the aac (6’)-1b-cr variant and beta-lactamase content

From: Ciprofloxacin-resistant Escherichia coli in Central Greece: mechanisms of resistance and molecular identification

Strain ID

Isolation date

Antimicrobial resistant pattern

ESBL

Phylogroup/ MLST ST (CC)

aac (6’)-Ib-cr

beta-lactamase content

GyrA:S83L + D87N/ ParC: S80I + E84V (n = 21)

347

13/6/2011

AM,AMC,CAZ,CTX,ATM,GM,NN,TE,SXT,CIP, NOR

positive

B2/ ST131

( − )

CTX-M-15

161

27/5/2011

AM,AMC,CAZ,CTX,ATM, NN,TE,SXT,CIP NOR

positive

B2/ ST131

( + )

CTX-M-15 + OXA-1

391

30/5/2011

AM,AMC,CAZ,CTX,ATM,GM,NN,TE,SXT,CIP,NOR

positive

B2/ ST131

( + )

CTX-M-15 + OXA-1

392

9/6/2011

AM,AMC,CAZ,CTX,ATM,GM,NN,TE,SXT,CIP,NOR

positive

B2/ ST131

( + )

CTX-M-15 + OXA-1

393

18/7/2011

AM,AMC,CAZ,CTX,ATM,GM,NN,TE,SXT,CIP,NOR

positive

B2/ ST131

( + )

CTX-M-15 + OXA-1

399

2/8/2011

AM,AMC,CAZ,CTX,ATM,GM,NN,TE,SXT,CIP,NOR

positive

B2/ ST131

( + )

CTX-M-15 + OXA-1

160

3/5/2011

AM,AMC,CAZ,CTX,ATM,SXT,CIP,NOR

positive

B2/ ST131

( + )

CTXM-15 + TEM-1

505

4/9/2011

AM,AMC,CAZ,CTX,ATM,AN,GM,NN,SXT,CIP,NOR

positive

B2/ ST131

( + )

CTX-M-15 + TEM-1 + OXA-1

397

4/8/2011

AM,AMC,CAZ,CTX,ATM,TE, SXT, CIP, NOR

positive

B2/ ST131

( − )

CTX-M-3

270

1/5/2011

AM,AMC,NN,SXT,CIP,NOR

negative

B2/ ST131

( + )

OXA-1

301

5/5/2011

AM, AMC,NN,TE,CIP,NOR

negative

B2/ ST131

( + )

OXA-1

307

6/6/2011

AM,AMC, GM, NN, TE,CIP, NOR

negative

B2/ ST131

( + )

OXA-1

252

1/5/2011

AM, SXT,CIP,NOR

negative

B2/ ST131

( − )

TEM-1

206

16/5/2011

AM,AMC,GM,TE,SXT,CIP,NOR

negative

B2/ ST131

( + )

TEM-1 + OXA-1

320

25/5/2011

AM,AMC,CIP,NOR

negative

B2/ ST131

( + )

TEM-1 + OXA-1

346

3/6/2011

AM,AMC,AN,GM,NN,SXT,TE,CIP,NOR

negative

B2/ ST131

( + )

TEM-1 + OXA-1

803

4/12/2011

AM,AMC,CAZ,CTX, IMP,MEM,CIP, NOR

negative

B2/ ST131

( + )

VIM-1-like + TEM-1+ OXA-1

220

5/5/2011

TE, SXT,CIP,NOR

negative

B2/ ST131

( − )

none

321

18/7/2011

CIP,NOR

negative

B2/ ST131

( − )

none

354

1/7/2011

TE,CIP,NOR

negative

B2/ ST131

( − )

none

355

15/8/2011

TE,SXT,CIP,NOR

negative

B2/ ST131

( − )

none

GyrA:S83L + D87N/ ParC: S80I + E84G (n = 1)

296

6/8/2011

AM, TE, CIP, NOR

negative

D/ ST393 (ST31 Cplx)

( + )

TEM-1

Strain ID

Isolation date

Antimicrobial susceptibility pattern

ESBL

Phylogroup/MLST ST (CC)

aac (6’)-Ib-cr

beta-lactamase content

GyrA:S83L + D87N/ ParC: S80I (n = 13)

148

9/6/2011

AM,AMC,CAZ,CTX,ATM,IMP,MEM,NN,SXT,CIP,NOR

positive

B2/ ST410

( + )

KPC-2 + CTXM-15 + TEM-1 + OXA-1

(ST23 Cplx)

182

17/5/2011

AM,AMC,CAZ,CTX,ATM,IMP,MEM,AN,NN,TE,CIP,NOR

positive

B2/ ST410

( + )

KPC-2 + CTXM-3 + TEM-1+ OXA-1

(ST23 Cplx)

252

10/6/2011

AM,AMC,CAZ,CTX,ATM,IMP,MEM,NN,TE,CIP,NOR

positive

B2/ ST410

( + )

KPC-2 + CTXM-3 + TEM-1 + OXA-1

(ST23 Cplx)

648

31/12/2011

AM,AMC,CAZ,CTX,IMP,MEM,NN,TE,CIP,NOR

negative

B2/ ST410

( − )

KPC-2 + TEM-1

(ST23 Cplx)

132

24/5/2011

AM,AMC,CAZ,CTX,ATM,AN,NN,TE,SXT,CIP,NOR

positive

B2/ ST410

( + )

CTXM-15 + TEM-1 + OXA-1

(ST23 Cplx)

281

15/8/2011

AM,AMC,CAZ,CTX,ATM,AN,GM,NN,TE,SXT,CIP,NOR

positive

B2/ ST410

( + )

CTXM-15 + OXA-1

(ST23 Cplx)

384

30/11/2011

AM,AMC,CAZ,CTX,ATM,AN,TE,SXT,CIP,NOR

positive

B2/ ST44

( + )

CTXM-15

(ST10 Cplx)

383

22/9/2011

AM,TE,SXT,CIP,NOR

negative

A/ ST90

( + )

TEM-1

(ST23 Cplx)

259

14/7/2011

AM,TE,SXT,CIP,NOR

negative

B1/ ST162

( + )

TEM-1

(ST469 Cplx)

328

10/9/2011

AM,SXT,CIP,NOR

negative

B2/ ST361

( − )

TEM-1

362

21/10/2011

AM,TE,SXT,CIP,NOR

negative

D/ ST393

( − )

TEM-1

(ST31 Cplx)

129

25/5/2011

AM,TE,SXT,CIP,NOR

negative

B2/ ST1140

( − )

TEM-1

327

9/6/2011

CIP, NOR

negative

A/ ST2509

( − )

none